A multi-disciplinary team of scientists at GE Global Research, the technology development arm for GE, have combined a stunning array of sensing and analytical capabilities, including motion analysis, thermal profiling, image classification/segmentation, 3D object reconstruction, and vapor detection into a single medical sensing device to assess and monitor the progression of pressure ulcers, or bed sores.
An agreement was reached today between Ensocare and New Jersey-based iMPak Health to include iMPak’s innovative medication management system, Kraken, as part of the Ensocare sales portfolio. Ensocare will serve as an authorized re-seller for the Kraken system, which may be sold alone or, in the future, as an integrated feature inside of Ensocare’s Sync and Connect software engines.
Engineers at Oregon State University have used “additive manufacturing” to create an improved type of glucose sensor for patients with Type 1diabetes, part of a system that should work better, cost less and be more comfortable for the patient.
While headlines recently surged over big organizations such as Intel, Apple, and the Michael J. Fox Foundation partnering to launch pilot studies on wearables, mobile apps, and big data for Parkinson's disease... a small, Cleveland, Ohio based company continued to do what it has done best for over a decade, innovate targeted and clinically validated assessment tools for individuals with Parkinson's, and deliver them globally.
According to a new report published by iData Research, urological ultrasound procedures make up over 30% of all ultrasound procedures in the United States. Due to the wide variety of organs and anatomical spaces included in the definition of urological ultrasound procedures, many specialties of physicians and technicians perform urological ultrasounds.
Apple® today announced ResearchKit™, an open source software framework designed for medical and health research, helping doctors and scientists gather data more frequently and more accurately from participants using iPhone® apps. World-class research institutions have already developed apps with ResearchKit for studies on asthma, breast cancer, cardiovascular disease, diabetes and Parkinson’s disease.* Users decide if they want to participate in a study and how their data is shared.
Vantage mHealthcare Inc., ("Vantage") or (the "Company") today announced that Vantage’s manufacturer expects to deliver 100 Health Sensors over the next month to hospitals and research facilities in the United States and New Zealand, advancing to the next phase of its research and development process, in order to prepare for human clinical trials.
AliveCor, Inc. announced today the launch of the latest version of the AliveECG app, with two new FDA-cleared and CE-marked automated detectors that allow patients and physicians to focus on the ECGs that matter most. The new mobile app instantly detects when an ECG is either Normal or unreadable.
A visually-impaired man can’t see the interviewer sitting across from him but knows that the questioner has a smile on his face.
Bruin Biometrics LLC, a medical technology company employing biometric sensors for earlier, more accurate detection of chronic, preventable conditions flagged by policy makers as high-priority today announced the publication of a new study in Journal of Tissue Viability. Newly released data validates that the Company’s SEM Scanner provides standardized and objective data for consistent diagnosis of early pressure ulcers across users of varying skill levels.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.